Use of peptide drugs for the treatment of osteoporosis and for bone regeneration
MX2016002862A
Unreleased macrocycles derived from disubstituted 1, 3- indoles with anti-carcinogenic activity|.
MX2016002380A
Graphene and nano-graphite by ultrasound-hase and its use as a reinforcing in polymeric matrix composites.
MX2016001586A
Equipment for vacuum thermal treatments with controlled atmosphere for flat surfaces.
MX2016001588A
Photon converter coating for improving solar cell efficiency and the process for manufacturing the same.
MX2015016930A
Use and pharmaceutical compositions containing coordination compounds with redox activity that is coordinated with the cellular dna.
MX2015016921A
Salvia amarissima diterpenes and their use as modulators of the multi-drug resistance in tumors.
MX2015016928A
Method for performing the electrodeposition process with periodic disturbances.
MX2015016929A
Ozone flotation foam reactor for microalgae separation for biofuel production.
MX2015016922A
Efficient catalytic systems for the formation of olefins.
MX2015016924A
Molecule liberation process covalently linked to a molecular antenna.
MX2015016923A
Bichromophoric sensor for measuring viscosity by fluorescence ratio.
MX2015016124A
Design and use of a titanium oxide nano-coating with amorphous atomic structure on surfaces of micro-structured biomedical devices with potential effect on the biological response of human mesenchymal cells.
MX2015015859A
Incubator for the cultivation and preservation of tissue fragments, functional or alive, and method to perform the preservation.
MX2015014745A
Process for obtaining biofuels from natural rubber microalgae oil.
US2017103504A1
System for the identification and quantification of helminth eggs in environmental samples
MX2015014220A
Manufacturing process for an oral administration immunogen for pigs with the actinobacillus pleuropneumoniae and glyceryl monooleate purified toxins in cubic phase.
MX2015014221A
Interference rna for reducing the human nav1.6 channel expression.
MX2015014112A
Al-si-cu-mg metallic foams and its production process.
MX2015013728A
Pharmaceutical composition to be administered by transdermal release through biodegradable polymer microneedles.
